Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Clinical Characteristics of Post-COVID-19 Persistent Cough in the Omicron Eraopen access

Authors
Kang Yu RiHuh Jin-YoungOh Ji-YoonLee Ji-HyangLee DaegeunKwon Hyouk-SooKim Tae-BumChoi Jae CholCho You SookChung Kian FanPark So-YoungSong Woo-Jung
Issue Date
May-2023
Publisher
대한천식알레르기학회
Keywords
Cough; COVID-19; asthma; Omicron era; cohort; longitudinal assessment; nitric oxide; post-COVID syndrome
Citation
Allergy, Asthma & Immunology Research, v.15, no.3, pp 395 - 405
Pages
11
Journal Title
Allergy, Asthma & Immunology Research
Volume
15
Number
3
Start Page
395
End Page
405
URI
https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/73606
DOI
10.4168/aair.2023.15.3.395
ISSN
2092-7355
2092-7363
Abstract
Cough is one of the most common symptoms of acute coronavirus disease 2019, but cough may persist for weeks or months. This study aimed to examine the clinical characteristics of patients with post-coronavirus disease (COVID) persistent cough in the Omicron era. We conducted a pooled analysis comparing 3 different groups: 1) a prospective cohort of post-COVID cough (> 3 weeks; n = 55), 2) a retrospective cohort of post-COVID cough (> 3 weeks; n = 66), and 3) a prospective cohort of non-COVID chronic cough (CC) (> 8 weeks; n = 100). Cough and health status was assessed using patient-reported outcomes (PROs). Outcomes, including PROs and systemic symptoms, were longitudinally evaluated in the prospective post-COVID cough registry participants receiving usual care. A total of 121 patients with post-COVID cough and 100 with non-COVID CC were studied. Baseline cough-specific PRO scores did not significantly differ between post-COVID cough and non-COVID CC groups. There were no significant differences in chest imaging abnormality or lung function between groups. However, the proportions of patients with fractional exhaled nitric oxide (FeNO) ≥ 25 ppb were 44.7% in those with post-COVID cough and 22.7% in those with non-COVID CC, which were significantly different. In longitudinal assessment of the post-COVID registry (n = 43), cough-specific PROs, such as cough severity or Leicester Cough Questionnaire (LCQ) scores, significantly improved between visits 1 and 2 (visit interval: median 35 [interquartile range, IQR: 23–58] days). In the LCQ score, 83.3% of the patients showed improvement (change ≥ +1.3), but 7.1% had worsened (≤ −1.3). The number of systemic symptoms was median 4 (IQR: 2–7) at visit 1 but decreased to median 2 (IQR: 0–4) at visit 2. In summary, post-COVID persistent cough was similar in overall clinical characteristics to CC. Current cough guideline-based approaches may be effective in most patients with post-COVID cough. Measurement of FeNO levels may also be useful for cough management.
Files in This Item
Appears in
Collections
ETC > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Choi, Jae Chol photo

Choi, Jae Chol
의과대학 (의학부(임상-광명))
Read more

Altmetrics

Total Views & Downloads

BROWSE